Easwaran Sreekumar

10PUBLICATIONS

24CO-AUTHORS

Medical infection agents (incl. prions)Forest health and pathologyInnate immunityMolecular medicineInfant and child health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 29, 2026

Cell type-dependent induction of type I interferon and PARP1 activation in astrocytes and neurons during chikungunya virus infection.

|Jan 24, 2026

Utility of Recombinant Envelope Domain III as a Diagnostic Antigen for the Specific Detection of Kyasanur Forest Disease.

Sayad Hafeez, Rajeshwara Achur, Vivek Vijay

|Apr 10, 2025

Assessing anti-rabies vaccine response in humans: A rapid and high-throughput adaptable, pseudovirus-based neutralization assay as an alternative to rapid fluorescent focus inhibition test (RFFIT).

Santhik S Lupitha, Geetu Rose Varghese, Lekshmi J Das

|Apr 07, 2025

Ponatinib and other clinically approved inhibitors of Src and Rho-A kinases abrogate dengue virus serotype 2- induced endothelial permeability.

Srishti Rajkumar Mishra, Ayan Modak, Mansi Awasthi

|Jan 10, 2025

Human bocavirus infections in paediatric patients in a tertiary care hospital in Kerala, India.

B Aneesh, Swapna K Pillai, P S Chippy

|Nov 30, 2023

Fingolimod (FTY720), an FDA-approved sphingosine 1-phosphate (S1P) receptor agonist, restores endothelial hyperpermeability in cellular and animal models of dengue virus serotype 2 infection.

Ayan Modak, Srishti Rajkumar Mishra, Mansi Awasthi

Pageof 2

Frequent Collaborators

Rachy Abraham

B Aneesh

Swapna K Pillai

P S Chippy

Megha Chandran

Arun V Jose

Lalitha Kailas

M Neziya

S Aswathyraj

Sreeja R Nair

Frequent Collaborators

Rachy Abraham

B Aneesh

Swapna K Pillai

P S Chippy